diprotin B: from Bacillus cereus BMF673-RF1; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Cereus | genus | [no description available] | Cactaceae | The cactus plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Cacti are succulent perennial plants well adapted to dry regions.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 146208 |
| CHEMBL ID | 3039071 |
| CHEBI ID | 166345 |
| SCHEMBL ID | 3125140 |
| MeSH ID | M0122934 |
| Synonym |
|---|
| brn 4268092 |
| l-leucine, n-(1-l-valyl-l-prolyl)- |
| n-(1-l-valyl-l-prolyl)-l-leucine |
| diprotin b |
| BSPBIO_003393 |
| KBIO3_002896 |
| SPBIO_002179 |
| SPECTRUM3_001807 |
| SPECTRUM2_001990 |
| NCGC00178096-01 |
| CHEBI:166345 |
| (2s)-2-[[(2s)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoic acid |
| 90614-49-6 |
| val-pro-leu |
| (2s)-2-[[(2s)-1-[(2s)-2-azaniumyl-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoate |
| valyl-prolyl-leucine |
| CHEMBL3039071 |
| CCG-39488 |
| SCHEMBL3125140 |
| h-val-pro-leu-oh |
| AKOS030525662 |
| (s)-2-((s)-1-((s)-2-amino-3-methylbutanoyl)pyrrolidine-2-carboxamido)-4-methylpentanoic acid |
| n-[hydroxy(1-valylpyrrolidin-2-yl)methylidene]leucine |
| DTXSID20920276 |
| l-valyl-l-prolyl-l-leucine |
| val-pro-leu-oh |
| CS-0034520 |
| HY-111173 |
| l-leucine,l-valyl-l-prolyl- |
| Class | Description |
|---|---|
| oligopeptide | A peptide containing a relatively small number of amino acids. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID977599 | Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6 | Structure-based identification of OATP1B1/3 inhibitors. |
| AID977602 | Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6 | Structure-based identification of OATP1B1/3 inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.57) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||